Archives
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2018-07
-
Nuclear cGAS-TRIM41 Axis Restricts L1 Retrotransposition via
2026-07-08
This study reveals how nuclear cGAS, upon phosphorylation by Chk2, promotes TRIM41-mediated ubiquitination and degradation of L1 ORF2p, thereby suppressing retrotransposition and preserving genome stability. These findings highlight a previously uncharacterized posttranslational regulatory mechanism important for aging and cancer research.
-
LY294002 (A8250): Optimizing PI3K Pathway Assays in Cell Res
2026-07-08
This article addresses real-world laboratory challenges in cell viability, proliferation, and cytotoxicity assays by spotlighting LY294002 (SKU A8250), a potent class I PI3K inhibitor. Through scenario-driven Q&A, it demonstrates how LY294002 ensures reproducible, data-backed results in PI3K/Akt/mTOR pathway investigations, with actionable insights for experimental design and protocol optimization.
-
Prunin Disrupts SVA IRES-Mediated Translation: Mechanistic I
2026-07-07
This study demonstrates that prunin, a natural IRES inhibitor, blocks Senecavirus A (SVA) replication by disrupting key host protein interactions at the viral internal ribosome entry site (IRES). These findings highlight a new antiviral mechanism and identify previously unrecognized IRES trans-acting factors involved in SVA translation.
-
(+)-Bicuculline: Technical Guidance for GABAA Antagonism Wor
2026-07-07
(+)-Bicuculline is a competitive GABAA receptor antagonist designed for precise modulation of inhibitory neurotransmission in neuroscience research. This product is not suited for diagnostic or clinical use and should be handled with strict adherence to solubility and storage protocols for reliable results.
-
O-GlcNAc-HUWE1-TfR1 Axis Regulates Ferroptosis in Preeclamps
2026-07-06
This study uncovers how O-GlcNAc modification stabilizes HUWE1, promoting TfR1 ubiquitination and reducing iron-induced ferroptosis in trophoblasts, a key mechanism in preeclampsia pathology. The findings suggest that targeting the O-GlcNAc–HUWE1–TfR1 pathway could offer innovative strategies for managing placental dysfunction and adverse pregnancy outcomes.
-
Mestranol Induces Reversible Lysosomal Stress in Zebrafish M
2026-07-06
This study demonstrates that mestranol, a synthetic estrogen, induces a reversible lysosomal storage–like state in zebrafish microglia in vivo. The findings establish a tractable model to study environmental estrogen impacts on microglial lysosomal function with implications for neuroimmunotoxicity and lysosomal disease research.
-
Murine RNase Inhibitor: Precision RNA Protection Beyond the
2026-07-05
Explore how Murine RNase Inhibitor advances RNA degradation prevention in molecular biology. This article unveils a unique protein-RNA protection mechanism, connecting cutting-edge assay reliability with new insights from extracellular RNA biology.
-
Tropifexor (LJN452): Advancing Intestinal Barrier Research
2026-07-04
Tropifexor (LJN452) stands out as a highly potent FXR signaling pathway modulator, enabling researchers to dissect epithelial barrier function and metabolic disease mechanisms with precision. Recent breakthroughs in neonatal piglet and patient-derived organoid models showcase its translational impact and offer practical blueprints for experimental design.
-
Annexin V-FITC/PI Apoptosis Assay Kit: Technical Guidance
2026-07-03
The Annexin V-FITC/PI Apoptosis Assay Kit enables rapid, fluorescence-based differentiation of viable, early apoptotic, and late apoptotic or necrotic cells, streamlining apoptosis quantification in research workflows. It is best suited for researchers needing practical and reproducible detection of apoptotic stages by flow cytometry or microscopy. This kit is not intended for diagnostic or clinical applications.
-
TaqI Restriction Endonuclease: Fast, Precise DNA Digestion
2026-07-03
TaqI Restriction Endonuclease (SKU K3053) is designed for rapid, sequence-specific cleavage of plasmid, PCR, and genomic DNA in molecular biology workflows. It efficiently generates sticky ends in as little as 5–15 minutes, streamlining cloning and DNA manipulation protocols. This product is not suitable for diagnostic or medical applications.
-
HNF4A-AS1 Modulates Sorafenib Resistance via Lipid Metabolis
2026-07-02
This study identifies the liver-specific lncRNA HNF4A-AS1 as a key regulator of resistance to sorafenib-induced ferroptosis in hepatocellular carcinoma (HCC) by modulating lipid metabolism pathways. The findings highlight a mechanistic link between HNF4A-AS1 expression, DECR1 regulation, and the cellular lipid environment, offering new insights for overcoming drug resistance in liver cancer.
-
Isradipine (Dynacirc): Advanced Workflows for Neuroprotectio
2026-07-02
Isradipine (Dynacirc) enables precise control of L-type calcium channel activity for both neuroprotective and vascular smooth muscle studies. This article guides researchers through advanced experimental design, troubleshooting, and reference-backed optimization, leveraging APExBIO's high-purity Isradipine for reproducible, high-impact results.
-
CARM1-Targeted Peptide Inhibitor Suppresses Breast Cancer Pr
2026-07-01
A newly developed peptide inhibitor, Pi-CARM1-TAT, selectively targets CARM1 and demonstrates potent suppression of breast cancer cell growth both in vitro and in vivo. This approach offers a promising avenue for overcoming endocrine therapy resistance and highlights the therapeutic potential of CARM1 inhibition in hormone receptor-positive breast cancer.
-
ETS1 Regulates Mitophagy in BPD via SENP2/HSPA8/FUNDC1 Axis
2026-07-01
The reference study identifies ETS1 as a key transcriptional regulator that protects against bronchopulmonary dysplasia (BPD) by suppressing mitochondrial damage-induced mitophagy through the SENP2/HSPA8/FUNDC1 axis. These findings provide new mechanistic insight into chaperone-mediated autophagy in neonatal lung disease and suggest novel molecular targets for therapeutic intervention.
-
Cy5 amine (non-sulfonated): Technical Guide and Workflow Par
2026-06-30
Cy5 amine (non-sulfonated) provides a bright, photostable labeling option for fluorescence microscopy and flow cytometry workflows that require a primary amine-functionalized, water-insoluble dye. It is not recommended for direct aqueous labeling or any diagnostic or clinical applications. Proper solvent handling and protocol execution are essential for optimal results.